National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 17861 [2024-05160]
Download as PDF
<![CDATA[
17861
Federal Register / Vol. 89, No. 49 / Tuesday, March 12, 2024 / Notices
Accomplishments; Broader Program
Impacts; Products and Dissemination;
Collaboration and Partnering Activities;
and Project Evaluation Activities.
Information will be prepopulated based
on the login credentials for the user
submitting the report and the specific
grant being reported. Not all grants will
have reportable activities under all
headings (e.g., not all grants have an
evaluation component embedded in the
project). However, most OASH grants
will have reportable information under
most headings. Program offices with
additional reporting programmatic
information collections will eventually
transition collection of any overlapping
data elements to this OASH PPR. During
the transition, OASH will not require
grant recipients to provide the same
information twice.
Likely Respondents: Members and
staff from academia, community
organizations, local/state/federal
government, private sector, and tribal
government and services organizations.
ANNUALIZED BURDEN HOUR TABLE
OASH PPR .......................................
OASH grant recipients .....................
800
3
1
2400
Total ...........................................
...........................................................
........................
........................
........................
2400
[FR Doc. 2024–05162 Filed 3–11–24; 8:45 am]
BILLING CODE 4150–48–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK X01 Central
Repository Non-renewable Sample Access
review meeting.
Date: April 4, 2024.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Peter J. Kozel, Ph.D.,
Scientific Review Officer, NIDDK/Scientific
Review Branch, National Institutes of Health,
6707 Democracy Blvd., Room 7009,
VerDate Sep<11>2014
19:36 Mar 11, 2024
Jkt 262001
Number of
respondents
Average
burden per
response
Respondents
(if necessary)
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses
per
respondents
Forms
(if necessary)
Bethesda, MD 20892, (301) 594–4721,
kozelp@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 6, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–05161 Filed 3–11–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Fellowship Review
Meeting.
Date: April 5, 2024.
Time: 12:00 p.m. to 1:00 p.m.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Total
burden hours
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: John F. Connaughton,
Ph.D., Chief, Scientific Review Officer,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 7347, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7797, connaughtonj@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 6, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–05160 Filed 3–11–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
E:\FR\FM\12MRN1.SGM
12MRN1
]]>Agencies
[Federal Register Volume 89, Number 49 (Tuesday, March 12, 2024)]
[Notices]
[Page 17861]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-05160]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Fellowship Review
Meeting.
Date: April 5, 2024.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, NIDDK, Democracy II, Suite
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: John F. Connaughton, Ph.D., Chief, Scientific
Review Officer, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 7347, 6707 Democracy Boulevard, Bethesda, MD 20892-
5452, (301) 594-7797, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: March 6, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-05160 Filed 3-11-24; 8:45 am]
BILLING CODE 4140-01-P
